Avantax Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $818K | Buy |
6,465
+128
| +2% | +$16.2K | ﹤0.01% | 1289 |
|
|
2025
Q1 | $810K | Buy |
6,337
+314
| +5% | +$40.2K | ﹤0.01% | 1197 |
|
|
2024
Q4 | $796K | Buy |
6,023
+1,064
| +21% | +$141K | 0.01% | 1158 |
|
|
2024
Q3 | $722K | Buy |
4,959
+247
| +5% | +$36K | ﹤0.01% | 1193 |
|
|
2024
Q2 | $647K | Sell |
4,712
-575
| -11% | -$78.9K | ﹤0.01% | 1208 |
|
|
2024
Q1 | $726K | Buy |
5,287
+1,466
| +38% | +$201K | 0.01% | 879 |
|
|
2023
Q4 | $519K | Sell |
3,821
-351
| -8% | -$47.7K | 0.01% | 963 |
|
|
2023
Q3 | $510K | Sell |
4,172
-171
| -4% | -$20.9K | 0.01% | 940 |
|
|
2023
Q2 | $551K | Sell |
4,343
-199
| -4% | -$25.3K | 0.01% | 903 |
|
|
2023
Q1 | $587K | Buy |
4,542
+769
| +20% | +$99.3K | 0.01% | 848 |
|
|
2022
Q4 | $495K | Sell |
3,773
-66
| -2% | -$8.67K | 0.01% | 870 |
|
|
2022
Q3 | $449K | Buy |
3,839
+50
| +1% | +$5.85K | 0.01% | 824 |
|
|
2022
Q2 | $446K | Buy |
3,789
+211
| +6% | +$24.8K | 0.01% | 832 |
|
|
2022
Q1 | $466K | Sell |
3,578
-160
| -4% | -$20.8K | 0.01% | 810 |
|
|
2021
Q4 | $571K | Sell |
3,738
-154
| -4% | -$23.5K | 0.01% | 718 |
|
|
2021
Q3 | $628K | Buy |
3,892
+516
| +15% | +$83.3K | 0.01% | 629 |
|
|
2021
Q2 | $551K | Buy |
3,376
+216
| +7% | +$35.3K | 0.01% | 672 |
|
|
2021
Q1 | $476K | Sell |
3,160
-16,568
| -84% | -$2.5M | 0.01% | 636 |
|
|
2020
Q4 | $3M | Sell |
19,728
-12,990
| -40% | -$1.97M | 0.07% | 191 |
|
|
2020
Q3 | $4.43M | Buy |
32,718
+8,341
| +34% | +$1.13M | 0.07% | 224 |
|
|
2020
Q2 | $3.33M | Buy |
24,377
+21,053
| +633% | +$2.88M | 0.1% | 156 |
|
|
2020
Q1 | $359K | Sell |
3,324
-9,326
| -74% | -$1.01M | 0.01% | 517 |
|
|
2019
Q4 | $1.53M | Buy |
12,650
+9,780
| +341% | +$1.18M | 0.04% | 259 |
|
|
2019
Q3 | $284K | Buy |
2,870
+765
| +36% | +$75.7K | 0.01% | 447 |
|
|
2019
Q2 | $230K | Buy |
2,105
+223
| +12% | +$24.4K | 0.01% | 452 |
|
|
2019
Q1 | $210K | Buy |
+1,882
| New | +$210K | 0.01% | 451 |
|